. 2021 Nov 4;186(1):R1–R14. doi: 10.1530/EJE-21-0794
This work is licensed under a Figure 2.
Challenges of CAH treatment. The current standard of care for patients with CAH is glucocorticoid therapy, which targets both the cortisol deficiency and the adrenal androgen excess.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.